Clinical Trial Update: Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pancreatic enzyme replacement after adjuvant chemotherapy in resected pancreatic adenocarcinoma was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• pancreatic enzyme replacement

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-08-03